Understanding the DUPLEX Trial and Sparsentan in FSGS, with Michelle Rheault, MD
Michelle Rheault, MD, provides additional perspective on the results of the DUPLEX trial, which examined sparsentan in patients with FSGS.
Source: hcplive.com
Focal Segmental News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Focal Segmental. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Focal Segmental Today - Breaking & Trending Today
Sparsentan Use Could Lower Risk of Kidney Failure, Death in FSGS
Although the DUPLEX trial missed its primary endpoint of eGFR slope in patients with FSGS, results point to greater reductions in proteinuria and in risk of kidney failure with sparsentan use relative to irbesartan—making its case for becoming a standard of care for the glomerular disease.
Source: hcplive.com
East Boston Neighborhood Health Center Discrimination Allegations – NECN
At least a dozen people, mainly low-income women, are being discriminated against by a community hospital, according to an immigrant advocacy group, which adds...
Source: necn.com
Thousands of Massachusetts residents need a lifesaving gift this holiday season
Nearly 4,700 people in Mass. are waiting for organs. Most need a kidney. Others on the list need a liver, a pancreas and even a heart.
Source: wcvb.com
Dimerix latest study offers hope for chronic obstructive pulmonary disease
Dimerix latest study offers hope for chronic obstructive pulmonary disease
Source: stockhead.com.au